Dipa Sheth
Research Subjects
Research Interests
Dipa Sheth has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Anand Sripada
Division of Allergy & Immunology, Department of Medicine, National Jewish Health, Denver, CO 1
1 shared publication - Brian P. O'COnnor
12Pfizer Inc., Bothell, Washington
1 shared publication - Divya Verma
National Jewish Health Denver Colorado USA
1 shared publication J. VanLancker
Washington, DC
1 shared publication- Jennifer R. Knapp
Center for Genes, Environment and Health, National Jewish Health , Denver, CO
1 shared publication - Jerome McKay
Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora, CO 80045, USA
1 shared publication
Latest Publications
- 9 November 2023
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 131 (5) , S120
DRUG ALLERGY OR MAST CELL ACTIVATION?
- 9 November 2023
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 131 (5) , S120
DRUG ALLERGY OR MAST CELL ACTIVATION?
- Open Access
- 2 June 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (7)
The molecular and epigenetic mechanisms of innate lymphoid cell (ILC) memory and its relevance for asthma
Repetitive exposure of Rag1−/− mice to the Alternaria allergen extract generated a form of memory that elicited an asthma-like response upon a subthreshold recall challenge 3–15 wk later. This memory was associated with lung ICOS+ST2+ ILC2s. Genetic, pharmacologic, and antibody-mediated inhibition and adoptive transfer established an essential role for ILC2s in memory-driven asthma. ATAC-seq demonstrated a distinct epigenetic landscape of memory ILC2s and identified Bach2 and AP1 (JunD and Fosl2) motifs as major drivers of altered gene accessibility. scRNA-seq, gene knockout, and signaling studies suggest that repetitive allergenic stress induces a gene repression program involving Nr4a2, Zeb1, Bach2, and JunD and a preparedness program involving Fhl2, FosB, Stat6, Srebf2, and MPP7 in memory ILC2s. A mutually regulated balance between these two programs establishes and maintains memory. The preparedness program (e.g., Fhl2) can be activated with a subthreshold cognate stimulation, which down-regulates repressors and activates effector pathways to elicit the memory-driven phenotype.
- 2 June 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (7)
Open AccessThe molecular and epigenetic mechanisms of innate lymphoid cell (ILC) memory and its relevance for asthma
Repetitive exposure of Rag1−/− mice to the Alternaria allergen extract generated a form of memory that elicited an asthma-like response upon a subthreshold recall challenge 3–15 wk later. This memory was associated with lung ICOS+ST2+ ILC2s. Genetic, pharmacologic, and antibody-mediated inhibition and adoptive transfer established an essential role for ILC2s in memory-driven asthma. ATAC-seq demonstrated a distinct epigenetic landscape of memory ILC2s and identified Bach2 and AP1 (JunD and Fosl2) motifs as major drivers of altered gene accessibility. scRNA-seq, gene knockout, and signaling studies suggest that repetitive allergenic stress induces a gene repression program involving Nr4a2, Zeb1, Bach2, and JunD and a preparedness program involving Fhl2, FosB, Stat6, Srebf2, and MPP7 in memory ILC2s. A mutually regulated balance between these two programs establishes and maintains memory. The preparedness program (e.g., Fhl2) can be activated with a subthreshold cognate stimulation, which down-regulates repressors and activates effector pathways to elicit the memory-driven phenotype.